Literature DB >> 28839080

Reply to Srivastava et al., "pH Conditions under Which Pyrazinamide Works in Humans".

Russell R Kempker1, Charles A Peloquin2, Henry M Blumberg3,4, Sergo Vashakidze5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28839080      PMCID： PMC5571346          DOI： 10.1128/AAC.01120-17

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  4 in total

1.  Pharmacokinetics-pharmacodynamics of pyrazinamide in a novel in vitro model of tuberculosis for sterilizing effect: a paradigm for faster assessment of new antituberculosis drugs.

Authors:  Tawanda Gumbo; Chandima S W Siyambalapitiyage Dona; Claudia Meek; Richard Leff
Journal:  Antimicrob Agents Chemother       Date:  2009-05-18       Impact factor: 5.191

2.  pH Conditions under Which Pyrazinamide Works in Humans.

Authors:  Shashikant Srivastava; Jotam G Pasipanodya; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

3.  Sterilizing Activity of Pyrazinamide in Combination with First-Line Drugs in a C3HeB/FeJ Mouse Model of Tuberculosis.

Authors:  Jean-Philippe Lanoix; Fabrice Betoudji; Eric Nuermberger
Journal:  Antimicrob Agents Chemother       Date:  2015-12-07       Impact factor: 5.191

Review 4.  Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis.

Authors:  Medea Gegia; Nicholas Winters; Andrea Benedetti; Dick van Soolingen; Dick Menzies
Journal:  Lancet Infect Dis       Date:  2016-11-17       Impact factor: 25.071
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.